Long-term prognosis after recovery from myocardial infarction: A community-based survey in Yamagata, Japan

Internal Medicine

Volumn 40, Issue 7, 2001, Pages 589-593

  Kubota, Isao ^a,b   Matsui, Motoyuki ^a   Ito, Hiroshi ^a   Saito, Mikio ^a   Yokoyama, Koichi ^a   Yasumura, Seiji ^a   Tomoike, Hitonobu ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b Okitama Public General Hospital   (Japan)

Author keywords

Cardiac death; Diabetes mellitus; Non cardiac death

Indexed keywords

AGE; AGED; ARTICLE; COMMUNITY CARE; FEMALE; HEALTH SURVEY; HEART INFARCTION; HUMAN; JAPAN; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; RISK FACTOR; TIME;

AGE FACTORS; AGED; AGED, 80 AND OVER; COMMUNITY HEALTH SERVICES; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POPULATION SURVEILLANCE; PROGNOSIS; RISK FACTORS; TIME FACTORS;

EID: 0035403572     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.589     Document Type: Article

References (18)

1. Ogawa H, Kawana M, Tamura K, Kimata S, Hosoda S. Long-term prognosis of medically treated patients with acute myocardial infarction and one-vessel coronary artery disease. Am J Cardiol 73: 158-163, 1994.
2. Saito M, Fukami K, Hiramori K, et al. Long-term prognosis of patients with acute myocardial infarction: Is mortality and morbidity as low as the incidence of ischemic heart disease in Japan? Am Heart J 113: 891-897, 1987.
3. Kanzaki H, Miyazaki S, Noguchi T, et al. Influence of calcium antagonists on long-term survival of patients treated with coronary angioplasty. Jpn Heart J 40: 11-21, 1999.
4. Hosoda S, Kimata S, Tamura K, et al. Follow-up of 2,733 patients with myocardial infarction. Jpn Circ J 59: 121-129, 1995.
5. Kubota I, Ito H, Yokoyama K, Yasumura S, Tomoike H. Early mortality after acute myocardial infarction. Observational study in Yamagata, 1993-1995. Jpn Circ J 62: 414-418, 1998.
6. Ito H, Kubota I, Yokoyama K, Yasumura S, Tomoike H. Angioplasty but not thrombolysis improves short-term mortality of acute myocardial infarction. A multicenter survey in Yamagata, Japan. Jpn Heart J 40: 383-389, 1999.
7. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. WHO MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in 4 continents. Circulation 90: 583-612, 1994.
8. The International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Volume 1, World Health Organization Distribution and Sales, Geneva, 1992.
9. Martin CA, Thompson PL, Armstrong BK, Hobbs MST, de Klerk N. Long-term prognosis after recovery from myocardial infarction. A nine year follow-up of the Perth Coronary Register. Circulation 68: 961-969, 1983.
10. Yano K, Grove JS, Reed DM, Chun HM. Determinants of the prognosis after a first myocardial infarction in a migrant Japanese population. The Honolulu Heart Program. Circulation 88: 2582-2595, 1993.
11. Gottlieb S, Boyko V, Harpaz D, et al. Long-term (three-year) prognosis of patients treated with reperfusion or conservatively after acute myocardial infarction. J Am Coll Cardiol 34: 70-82, 1999.
12. Goldberg RJ, Gore JM, Gurwitz JH, et al. The impact of age on the incidence and prognosis of initial acute myocardial infarction. The Worcester Heart Attack Study. Am Heart J 117: 543-549, 1989.
13. Jacobs DR Jr, Kroenke C, Crow R, et al. PREDICT: A simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina. The Minnesota Heart Survey. Circulation 100: 599-607, 1999.
14. Buchwald H, Varco RL, Matts JP, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the program on the surgical control of the hyperlipidemia (PORSH). N Eng J Med 323: 946-955, 1990.
15. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389, 1994.
16. Lenderink T, Simoons ML, Van Es GA, Van de Werf, Verstraete M, Arnold AER, and The European Cooperative Study Group. Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. Circulation 92: 1110-1116, 1995.
17. Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 90: 2103-2114, 1994.
18. Barron HV, Bowlby LJ, Breen T, et al. Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Circulation 97: 1150-1156, 1998.